CELZ
Income statement / Annual
Last year (2023), Creative Medical Technology Holdings, Inc.'s total revenue was $9,000.00,
a decrease of 89.84% from the previous year.
In 2023, Creative Medical Technology Holdings, Inc.'s net income was -$5.29 M.
See Creative Medical Technology Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$9,000.00 |
$88,600.00 |
$87,754.00 |
$164,500.00 |
$165,500.00 |
$124,400.00 |
$4,800.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$3,600.00
|
$28,491.00
|
$47,949.00
|
$50,596.00
|
$45,499.00
|
$70,375.00
|
$8,000.00
|
$766,072.00
|
$0.00
|
$0.00
|
Gross Profit |
$5,400.00
|
$60,109.00
|
$39,805.00
|
$113,904.00
|
$120,001.00
|
$54,025.00
|
-$3,200.00
|
-$766,072.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0.6
|
0.68
|
0.45
|
0.69
|
0.73
|
0.43
|
-0.67
|
0
|
0
|
0
|
Research and Development Expenses |
$1.97 M
|
$6.27 M
|
$109,180.00
|
$0.00
|
$0.00
|
$96,621.00
|
$260,085.00
|
$85,334.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.22 M
|
$1.05 M
|
$898,526.00
|
$664,984.00
|
$20,831.00
|
$19,426.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$3.56 M
|
$3.94 M
|
$2.96 M
|
$1.16 M
|
$1.22 M
|
$1.05 M
|
$898,526.00
|
$664,984.00
|
$20,831.00
|
$19,426.00
|
Other Expenses |
$94,584.00
|
$92,084.00
|
$92,084.00
|
$66,792.00
|
$26,950.00
|
$21,144.00
|
$0.00
|
$9,356.00
|
$0.00
|
$0.00
|
Operating Expenses |
$5.63 M
|
$10.30 M
|
$3.17 M
|
$1.23 M
|
$1.25 M
|
$1.17 M
|
$1.17 M
|
$759,674.00
|
$20,831.00
|
$19,426.00
|
Cost And Expenses |
$5.63 M
|
$10.33 M
|
$3.21 M
|
$1.28 M
|
$1.30 M
|
$1.24 M
|
$1.18 M
|
$759,674.00
|
$20,831.00
|
$19,426.00
|
Interest Income |
$333,558.00
|
$100,328.00
|
$4.28 M
|
$1.23 M
|
$1.90 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$4.28 M
|
$1.23 M
|
$1.90 M
|
$1.36 M
|
$377,587.00
|
$6,398.00
|
$9,930.00
|
$8,586.00
|
Depreciation & Amortization |
$94,584.00
|
$92,084.00
|
$92,084.00
|
$66,792.00
|
$26,950.00
|
$21,144.00
|
$15,994.00
|
$9,356.00
|
$0.00
|
$0.00
|
EBITDA |
-$5.53 M |
-$10.15 M |
-$3.03 M |
-$1.05 M |
-$1.10 M |
-$1.09 M |
-$1.16 M |
-$750,318.00 |
-$20,831.00 |
-$19,426.00 |
EBITDA Ratio |
-613.95
|
-113.45
|
-34.57
|
-6.37
|
-6.67
|
-8.79
|
-242.04
|
0
|
0
|
0
|
Operating Income Ratio |
-624.46
|
-115.62
|
-35.62
|
-6.78
|
-6.83
|
-8.96
|
-245.38
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$333,558.00
|
$100,328.00
|
$22.34 M
|
-$35.21 M
|
-$7.35 M
|
-$12.54 M
|
-$1.48 M
|
-$6,398.00
|
-$9,930.00
|
-$8,586.00
|
Income Before Tax |
-$5.29 M
|
-$10.14 M
|
$19.21 M
|
-$36.33 M
|
-$8.48 M
|
-$13.66 M
|
-$2.66 M
|
-$766,072.00
|
-$30,761.00
|
-$28,012.00
|
Income Before Tax Ratio |
-587.4
|
-114.49
|
218.93
|
-220.82
|
-51.26
|
-109.77
|
-553.98
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$100,328.00
|
$4.28 M
|
$1.23 M
|
$1.90 M
|
-$11.18 M
|
$377,587.00
|
$12,796.00
|
$0.00
|
$0.00
|
Net Income |
-$5.29 M
|
-$10.04 M
|
$14.93 M
|
-$37.55 M
|
-$10.38 M
|
-$13.66 M
|
-$2.66 M
|
-$766,072.00
|
-$30,761.00
|
-$28,012.00
|
Net Income Ratio |
-587.4
|
-113.36
|
170.17
|
-228.3
|
-62.71
|
-109.77
|
-553.98
|
0
|
0
|
0
|
EPS |
-3.76 |
-9.19 |
57.32 |
-648.1 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
-1281.71 |
-1167.17 |
EPS Diluted |
-3.76 |
-9.19 |
45.97 |
-648.1 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
-1281.71 |
-1167.17 |
Weighted Average Shares Out |
$1.41 M
|
$1.09 M
|
$260,505.00
|
$57,946.00
|
$2,068.53
|
$1,203.00
|
$153.00
|
$140.00
|
$24.00
|
$24.00
|
Weighted Average Shares Out Diluted |
$1.41 M
|
$1.09 M
|
$324,861.00
|
$57,946.00
|
$2,068.53
|
$1,203.00
|
$153.00
|
$140.00
|
$24.00
|
$24.00
|
Link |
|
|
|
|
|
|
|
|
|
|